Abstract
In both men and women, age-related loss of sex steroid hormones has been linked to an increased risk for Alzheimer's disease (AD). The primary female hormone estrogen, and the primary male hormone testosterone have numerous protective effects in the brain relevant to the prevention of AD such as the promotion of neuron viability, reduction of β- amyloid accumulation and alleviation of tau hyperphosphorylation. Therefore it has been hypothesized that the precipitous loss of these hormones either through menopause or normal aging, can increase susceptibility to AD pathogenesis. This review will discuss the basic science research and epidemiological evidence largely supporting this hypothesis, as well as the estrogen-based hormone therapy clinical findings that have recently shed doubt on this theory. The complications associated with estrogen-based hormone therapy such as the inclusion of a progestogen, hormone responsiveness with age, and natural vs. synthetic hormones will be discussed. Further, we will outline the cancer risks facing both estrogen and testosterone-based hormone therapy. Most importantly, this review will discuss the present and future strategies to translate the neuroprotective properties of sex steroid hormon...Continue Reading
Citations
Apr 16, 2013·PloS One·Telma QuintelaCecília R A Santos
Jul 30, 2014·Translational Psychiatry·A N BegumD W Ethell
May 15, 2018·Frontiers in Aging Neuroscience·Alessandra MoscaStefano L Sensi
Jan 17, 2020·The European Journal of Neuroscience·Meagan R ConnerMary F Kritzer
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Pourrabi SeyedrezaHossini Seyedebrahim
Mar 12, 2013·TheScientificWorldJournal·Benoît Leclerc, Abedelnasser Abulrob
Sep 17, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Laure CarcaillonPierre-Yves Scarabin
Oct 29, 2014·Neurochemical Research·Lelin BingHengbing Zu
Dec 24, 2014·Molecular Neurobiology·Na QuQing Tian
Jul 24, 2014·Basic & Clinical Pharmacology & Toxicology·Yi Long DongHai Jing Yu
Apr 24, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Yan HuangYong-Xiang Zhang
Feb 26, 2015·Pharmacological Reports : PR·Anil Kumar Ekavali
Sep 30, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Iwona BojarMariusz Gujski
Jan 10, 2017·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Jhen-Hao JhanChia-Chun Tsai
Jun 22, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·G P IvanovaL M Vasilenko
May 8, 2018·Neuromolecular Medicine·Milad HasanpourReza Rahbarghazi
May 18, 2020·Journal of Alzheimer's Disease : JAD·Yixuan Amy PeiHan-Ting Zhang
Nov 21, 2012·Critical Care Medicine·Eric R Prossnitz
Dec 4, 2019·Phytotherapy Research : PTR·Fernanda Dos Santos PetryVera Maria Treis Trindade
Sep 20, 2015·Journal of Neurochemistry·Seung-Wan SonChang-Gue Son
Jul 19, 2015·Journal of Aging and Health·Dean SherzaiMagda Shaheen
Mar 26, 2021·Neurobiology of Aging·Firat KaraMarleen Verhoye
Jul 30, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nelsan PourhadiAmani Meaidi